RINVOQ® logo

RINVOQ® (upadacitinib) is a once-daily tablet used to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Atopic Dermatitis, Ulcerative Colitis & Crohn's Disease

Choose relevant condition

RA PsA
AD AS
UC CD

What is RINVOQ®?

RINVOQ® targets underlying inflammation to relieve symptoms of four chronic autoimmune conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Atopic Dermatitis (eczema), Ulcerative colitis and Crohn's Disease. Learn more about how RINVOQ® works.

Learn more

How to take RINVOQ®

To get the best out of your RINVOQ® treatment, it is important to follow your doctor's instructions. Get more information on how and when to take RINVOQ®.

Learn more

RINVOQ® Safety Information

Important safety information about RINVOQ® that you should know before taking RINVOQ®.



Learn more

Information on these pages should be discussed with your doctor and does not replace a doctor’s advice.

References: 1. RINVOQ® Approved Consumer Medicine Information. 2. RINVOQ® Approved New Zealand Data Sheet.

NZ-RNQ-220008. ABB2373. Date prepared March 2023.